About Us

At Ambrx, our mission is to discover and develop a pipeline of Engineered Precision Biologics as treatments for various cancer indications with a high unmet medical need.

Our internal pipeline is focused on creating next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system for a variety of cancer indications, including our lead product candidate ARX517, a prostate-specific membrane antigen (PSMA) targeting ADC. We have established collaborations with multiple pharmaceutical companies including NovoCodex Biopharmaceuticals, Sino Biopharmaceuticals, and BeiGene in additional indications and development projects.

Our team of dedicated professionals is bound by a culture and vision that embraces innovation, practicality, and accountability. Through these shared values, we relentlessly pursue our mission of bringing engineered precision biologics to patients in need of new targeted and stable treatment options. Visit our Careers page for information about joining our team.

What is an Engineered Precision Biologic?

EPBs are therapies we create using our expanded genetic code technology platform. Harnessing the power of this proprietary technology, we are able to precisely incorporate novel synthetic amino acids (SAA) in proteins, all within a living cell. The result is product candidates specifically designed to overcome the inherent limitations of conventional conjugation approaches that use natural amino acids for non-site-specific conjugation – offering potential safety and efficacy benefits to patients.

Leadership

Chief Executive Officer,
President and Director

Chief Financial Officer

Chief Operating Officer

Chief Scientific Officer
and General Manager China

Chief Clinical Officer

Chief Technology Officer

Board of Directors

Stephen Glover

Chair

Daniel O’Connor

Member

Xiaowei Chang, C.F.A.

Member

Kate Hermans

Member

Janet Loesberg, Pharm. D

Member

Paul Maier

Member

Scientific Advisory Board

Peter Schultz, Ph.D.

President and CEO of Scripps Research and a Professor of Chemistry.

Stuart Lutzker, M.D., Ph.D.

Jakob Dupont, M.D.

Melissa Starovasnik, Ph.D.,

Luisa Salter-Cid, Ph.D., M.Sc.

Contact Us

Ambrx, Inc.
10975 North Torrey Pines Road
La Jolla, CA 92037
Tel: (858) 875-2400

Business Development
bd@ambrx.com

Expanded Access Inquiry
expanded.access@ambrx.com

Media Inquiry
media@ambrx.com